The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation

Preterm birth is defined as delivery at <37 weeks of gestational age (GA) and exposes 15 million infants worldwide to serious early life diseases. Lowering the age of viability to 22 weeks GA entailed provision of intensive care to a greater number of extremely premature infants. Moreover, im...

Full description

Bibliographic Details
Main Authors: Josephine C. Owen, Steven P. Garrick, Briana M. Peterson, Philip J. Berger, Marcel F. Nold, Arvind Sehgal, Claudia A. Nold-Petry
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2023.1130013/full
_version_ 1797884395591303168
author Josephine C. Owen
Josephine C. Owen
Steven P. Garrick
Steven P. Garrick
Briana M. Peterson
Briana M. Peterson
Philip J. Berger
Philip J. Berger
Marcel F. Nold
Marcel F. Nold
Marcel F. Nold
Arvind Sehgal
Arvind Sehgal
Claudia A. Nold-Petry
Claudia A. Nold-Petry
author_facet Josephine C. Owen
Josephine C. Owen
Steven P. Garrick
Steven P. Garrick
Briana M. Peterson
Briana M. Peterson
Philip J. Berger
Philip J. Berger
Marcel F. Nold
Marcel F. Nold
Marcel F. Nold
Arvind Sehgal
Arvind Sehgal
Claudia A. Nold-Petry
Claudia A. Nold-Petry
author_sort Josephine C. Owen
collection DOAJ
description Preterm birth is defined as delivery at <37 weeks of gestational age (GA) and exposes 15 million infants worldwide to serious early life diseases. Lowering the age of viability to 22 weeks GA entailed provision of intensive care to a greater number of extremely premature infants. Moreover, improved survival, especially at extremes of prematurity, comes with a rising incidence of early life diseases with short- and long-term sequelae. The transition from fetal to neonatal circulation is a substantial and complex physiologic adaptation, which normally happens rapidly and in an orderly sequence. Maternal chorioamnionitis or fetal growth restriction (FGR) are two common causes of preterm birth that are associated with impaired circulatory transition. Among many cytokines contributing to the pathogenesis of chorioamnionitis-related perinatal inflammatory diseases, the potent pro-inflammatory interleukin (IL)-1 has been shown to play a central role. The effects of utero-placental insufficiency-related FGR and in-utero hypoxia may also be mediated, in part, via the inflammatory cascade. In preclinical studies, blocking such inflammation, early and effectively, holds great promise for improving the transition of circulation. In this mini-review, we outline the mechanistic pathways leading to abnormalities in transitional circulation in chorioamnionitis and FGR. In addition, we explore the therapeutic potential of targeting IL-1 and its influence on perinatal transition in the context of chorioamnionitis and FGR.
first_indexed 2024-04-10T04:06:59Z
format Article
id doaj.art-2f38a545ab6f4be389709b70050b4fb2
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-04-10T04:06:59Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-2f38a545ab6f4be389709b70050b4fb22023-03-13T04:40:37ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602023-03-011110.3389/fped.2023.11300131130013The role of interleukin-1 in perinatal inflammation and its impact on transitional circulationJosephine C. Owen0Josephine C. Owen1Steven P. Garrick2Steven P. Garrick3Briana M. Peterson4Briana M. Peterson5Philip J. Berger6Philip J. Berger7Marcel F. Nold8Marcel F. Nold9Marcel F. Nold10Arvind Sehgal11Arvind Sehgal12Claudia A. Nold-Petry13Claudia A. Nold-Petry14Ritchie Centre, Hudson Institute of Medical Research, Melbourne, VIC, AustraliaDepartment of Paediatrics, Monash University, Melbourne, VIC, AustraliaRitchie Centre, Hudson Institute of Medical Research, Melbourne, VIC, AustraliaDepartment of Paediatrics, Monash University, Melbourne, VIC, AustraliaRitchie Centre, Hudson Institute of Medical Research, Melbourne, VIC, AustraliaDepartment of Paediatrics, Monash University, Melbourne, VIC, AustraliaRitchie Centre, Hudson Institute of Medical Research, Melbourne, VIC, AustraliaDepartment of Paediatrics, Monash University, Melbourne, VIC, AustraliaRitchie Centre, Hudson Institute of Medical Research, Melbourne, VIC, AustraliaDepartment of Paediatrics, Monash University, Melbourne, VIC, AustraliaMonash Newborn, Monash Children’s Hospital, Melbourne, VIC, AustraliaDepartment of Paediatrics, Monash University, Melbourne, VIC, AustraliaMonash Newborn, Monash Children’s Hospital, Melbourne, VIC, AustraliaRitchie Centre, Hudson Institute of Medical Research, Melbourne, VIC, AustraliaDepartment of Paediatrics, Monash University, Melbourne, VIC, AustraliaPreterm birth is defined as delivery at <37 weeks of gestational age (GA) and exposes 15 million infants worldwide to serious early life diseases. Lowering the age of viability to 22 weeks GA entailed provision of intensive care to a greater number of extremely premature infants. Moreover, improved survival, especially at extremes of prematurity, comes with a rising incidence of early life diseases with short- and long-term sequelae. The transition from fetal to neonatal circulation is a substantial and complex physiologic adaptation, which normally happens rapidly and in an orderly sequence. Maternal chorioamnionitis or fetal growth restriction (FGR) are two common causes of preterm birth that are associated with impaired circulatory transition. Among many cytokines contributing to the pathogenesis of chorioamnionitis-related perinatal inflammatory diseases, the potent pro-inflammatory interleukin (IL)-1 has been shown to play a central role. The effects of utero-placental insufficiency-related FGR and in-utero hypoxia may also be mediated, in part, via the inflammatory cascade. In preclinical studies, blocking such inflammation, early and effectively, holds great promise for improving the transition of circulation. In this mini-review, we outline the mechanistic pathways leading to abnormalities in transitional circulation in chorioamnionitis and FGR. In addition, we explore the therapeutic potential of targeting IL-1 and its influence on perinatal transition in the context of chorioamnionitis and FGR.https://www.frontiersin.org/articles/10.3389/fped.2023.1130013/fullperinatal inflammationtransitional circulationinterleukin-1chorioamnionitisfetal growth restriction
spellingShingle Josephine C. Owen
Josephine C. Owen
Steven P. Garrick
Steven P. Garrick
Briana M. Peterson
Briana M. Peterson
Philip J. Berger
Philip J. Berger
Marcel F. Nold
Marcel F. Nold
Marcel F. Nold
Arvind Sehgal
Arvind Sehgal
Claudia A. Nold-Petry
Claudia A. Nold-Petry
The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation
Frontiers in Pediatrics
perinatal inflammation
transitional circulation
interleukin-1
chorioamnionitis
fetal growth restriction
title The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation
title_full The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation
title_fullStr The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation
title_full_unstemmed The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation
title_short The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation
title_sort role of interleukin 1 in perinatal inflammation and its impact on transitional circulation
topic perinatal inflammation
transitional circulation
interleukin-1
chorioamnionitis
fetal growth restriction
url https://www.frontiersin.org/articles/10.3389/fped.2023.1130013/full
work_keys_str_mv AT josephinecowen theroleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT josephinecowen theroleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT stevenpgarrick theroleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT stevenpgarrick theroleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT brianampeterson theroleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT brianampeterson theroleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT philipjberger theroleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT philipjberger theroleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT marcelfnold theroleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT marcelfnold theroleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT marcelfnold theroleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT arvindsehgal theroleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT arvindsehgal theroleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT claudiaanoldpetry theroleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT claudiaanoldpetry theroleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT josephinecowen roleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT josephinecowen roleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT stevenpgarrick roleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT stevenpgarrick roleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT brianampeterson roleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT brianampeterson roleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT philipjberger roleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT philipjberger roleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT marcelfnold roleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT marcelfnold roleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT marcelfnold roleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT arvindsehgal roleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT arvindsehgal roleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT claudiaanoldpetry roleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation
AT claudiaanoldpetry roleofinterleukin1inperinatalinflammationanditsimpactontransitionalcirculation